Strategic Vision Chris Boshoff, M.D., Ph.D., Pfizers Chief Scientific Officer , reaffirmed that cardiometabolic research is a strategic priority expected to be a key driver of growth for the company
A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia
By Molecule Class, Semaglutide Leads Today but Cedes Leadership by 2035 Semaglutide holds a commanding 58% share of the obesity GLP-1 market in 2025, underpinned by robust clinical validation from the STEPandSELECT trials, proven cardiovascular benefits, and extensive real-world use
It hosts a diverse array of microorganisms, including bacteria, and is influenced by multiple factors, such as changes in pH, temperature, sebum content, and moisture, which all affect the bacterial composition